IDEAYA Biosciences Reports Financial Results for the Third Quarter 2026 and Provides a Business Update SOUTH SAN FRANCISCO, Calif., Nov. 3, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery, development and commercialization of targeted therapeutics, today reported financial results for the third quarter ended September 30, 2026, and provided a business update. "We are encouraged by the continued momentum at IDEAYA during the third ...